Abstract B54: Type II interleukin 1 receptor-modulated SET/PP2A/p-ERK signaling is associated with regorafenib resistance in human colorectal cancer cells
2016 ◽
2013 ◽
Vol 383
(1-2)
◽
pp. 179-189
◽
2000 ◽
Vol 185
(2)
◽
pp. 293-301
◽